TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $56 | -100.0% | 37,452 | -76.4% | 0.01% | -89.8% |
| Q1 2022 | $438,000 | +26.2% | 158,593 | +113.2% | 0.06% | +34.1% |
| Q4 2021 | $347,000 | -44.6% | 74,402 | +1.1% | 0.04% | -31.2% |
| Q3 2021 | $626,000 | +19.5% | 73,579 | +130.4% | 0.06% | +8.5% |
| Q2 2021 | $524,000 | +137.1% | 31,942 | +218.6% | 0.06% | +59.5% |
| Q1 2021 | $221,000 | +5.2% | 10,025 | +47.7% | 0.04% | +8.8% |
| Q4 2020 | $210,000 | – | 6,788 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $34,473,000 | 7.99% |
| MPM BioImpact LLC | 3,370,982 | $28,687,000 | 4.45% |
| Ghost Tree Capital, LLC | 477,323 | $4,062,000 | 1.19% |
| Redmile Group, LLC | 3,816,709 | $32,480,000 | 0.57% |
| First Light Asset Management, LLC | 620,887 | $5,284,000 | 0.35% |
| AlphaCentric Advisors LLC | 113,000 | $962,000 | 0.24% |
| Cormorant Asset Management, LP | 479,506 | $4,081,000 | 0.17% |
| Artal Group S.A. | 750,000 | $6,383,000 | 0.14% |
| X-Square Capital, LLC | 32,003 | $272,000 | 0.14% |
| Altium Capital Management LP | 59,150 | $503,000 | 0.13% |